Cefepime Powder For Solution For Injection 1G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cefepime: Powder for solution for injection (1g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CEFEPIME (SEF e pim) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information
Select a Medication

Cefepime 1g Powder for Injection

NDC: 250210121
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bacteremia, Pneumonia, Febrile Neutropenia, Pyelonephritis, Intraabdominal Infections, Skin And Skin Structure Infections, Urinary Tract Infection (UTI), Nosocomial Pneumonia, Community-acquired Pneumonia

Sometimes used for but not FDA approved for the following conditions:
Gynecologic Infections

Storage Information
Store unreconstituted product at 68 to 77 degrees F; excursions permitted to 59 to 86 degrees F
Protect from light
Reconstituted product may be stored up to 24 hours at controlled room temperature (68 to 77 degrees F) or up to 7 days refrigerated (36 to 46 degrees F)
Cefepime 1g Powder for Injection

Reported Side Effects for Cefepime 1g Powder for Injection

Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Vaginal Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Kidney Function Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Redness Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Colon Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
High Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Phosphate Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
0.6-3.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
1.1-4.0%*
Severity: MILD
Onset: EARLY
Irritated Blood Vessels Incidence:
1.3%*
Severity: MODERATE
Onset: RAPID
Low Prothrombin Level Incidence:
1.4-1.6%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
1.7%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
2.4-2.8%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
2.8%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cefepime

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5